A.J. Lacave
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Surgery top 10%
- Esophageal Cancer Research and Treatment
- Colorectal and Anal Carcinomas
- Esophageal and GI Pathology
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 2
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Harry Bleiberg (2 shared papers)G.H. Blijham (2 shared papers)Tarek Sahmoud (3 shared papers)M. Namer (2 shared papers)J H Jacob (1 shared paper)B Paillot (1 shared paper)Pietro De Besi (1 shared paper)Francesca Gay (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (3 papers)European Journal of Cancer (3 papers)Journal of Clinical Oncology (2 papers)Gynecologic Oncology (2 papers)Mutagenesis (1 paper)
- Partner nations
- SpainBelgiumNetherlands
In The Last Decade
A.J. Lacave
16 papers receiving 493 citations
Peers
Comparison fields: 5 of 50
- Obstetrics and Gynecology 105
- Surgery 234
- Oncology 134
- Pulmonary and Respiratory Medicine 144
- Epidemiology 84
Countries citing papers authored by A.J. Lacave
This map shows the geographic impact of A.J. Lacave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J. Lacave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J. Lacave more than expected).
Fields of papers citing papers by A.J. Lacave
This network shows the impact of papers produced by A.J. Lacave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J. Lacave. The network helps show where A.J. Lacave may publish in the future.
Co-authors
The 25 scholars most cited alongside A.J. Lacave, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 236 | |
| 2 | 2001 | 57 | |
| 3 | 1990 | 37 | |
| 4 | 1985 | 34 | |
| 5 | 2001 | 33 | |
| 6 | 1989 | 29 | |
| 7 | 1995 | 18 | |
| 8 | Phase I trial of intermittent high-dose dacarbazine. | 1984 | 17 |
| 9 | 2012 | 15 | |
| 10 | 2001 | 14 | |
| 11 | 1999 | 9 | |
| 12 | 1995 | 7 | |
| 13 | 2000 | 5 | |
| 14 | 2011 | 2 | |
| 15 | 2003 | 1 | |
| 16 | 2004 | 1 |
About A.J. Lacave
A.J. Lacave is a scholar working on Oncology, Epidemiology, Obstetrics and Gynecology, Surgery and Molecular Biology, having authored 16 papers that have together received 515 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Endometrial and Cervical Cancer Treatments (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Gastric Cancer Management and Outcomes (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Obstetrics and Gynecology (105 citations), Surgery (234 citations), Oncology (134 citations), Pulmonary and Respiratory Medicine (144 citations) and Epidemiology (84 citations). A.J. Lacave has collaborated with scholars based in Spain, Belgium and Netherlands. Frequent co-authors include Harry Bleiberg, G.H. Blijham, Tarek Sahmoud, M. Namer, J H Jacob, B Paillot, Pietro De Besi, Francesca Gay, Laurent Bedenne and Laurence Collette. Their work appears in journals such as Breast Cancer Research and Treatment, European Journal of Cancer, Journal of Clinical Oncology, Gynecologic Oncology and Mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.